| CTVA |
Report |
Operating EPS |
BEAT |
pred ~$2.30 vs. cons $2.25 |
MEDIUM |
| CTVA |
Report |
Total revenue |
IN-LINE |
pred ~$6.65B vs. cons $6.589B |
MEDIUM |
| CTVA |
Report |
Crop Protection revenue |
IN-LINE |
pred ~$1.96B vs. cons $1.950B |
MEDIUM |
| CTVA |
Guide |
Operating EBITDA (FY2026) |
LOWER |
guide ~$4.0B-$4.2B vs. cons $4.203B |
MEDIUM |
| CTVA |
Guide |
Operating EPS (FY2026) |
LOWER |
guide ~$3.45-$3.70 vs. cons $3.781 |
MEDIUM |
| CTVA |
Guide |
Separation dis-synergies (FY2026) |
BETTER |
update more favorable than initial $100M net EBITDA estimate |
MEDIUM |
| CTVA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| CTVA |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — maintained FY guide below consensus |
LOW |